Immune to Cancer: The CRI Blog
-
Immunotherapy Combination Approved as First-Line Option for Patients with Advanced Triple-Negative Breast Cancer
Patients with advanced triple-negative breast cancer can now receive frontline treatment with immunotherapy in combination with chemotherapy.
-
Spin to Give to Cancer Research Institute
Laura Geminiana organized a unique birthday fundraiser this year: a spin class where she and members donated…
-
Charles Graeber Follows Glimmers of Light Leading to the Breakthrough Emergence of Cancer Immunotherapy
An interview with bestselling author Charles Graeber about his new book, The Breakthrough: Immunotherapy and the Race…
-
Research, Data, and Healthcare Access for Rare Cancers
Dr. Jill O’Donnell-Tormey participated in an expert panel discussion on rare cancers for The Forum at the…
-
A Golf Tournament Honoring Two Brothers’ Legacy
Trevor Smith honored his father and uncle with the Fourth Annual Jim and Jerry Smith Memorial Golf…
-
Scientist Spotlight: Monica Olcina, DPhil
Dr. Monica Olcina, a CRI-funded fellow at Stanford University, discusses her work on the complement system and…
-
IO360 2019 Preview: Collaboration, Investment, Clinical Trials, and Combinations
The fifth annual Immuno-Oncology 360° conference will be held on February 6-8, 2019 in New York City.
-
Markiplier Bares All for Cancer Research
YouTube celebrity Markiplier created and sold a humorous calendar, donating the proceeds to the Cancer Research Institute.
-
Curtis Garbett’s Immunotherapy Story
Bladder Cancer | Diagnosed 2015 Advancing cancer research and visioning a future immune to bladder cancer Curtis’s Story…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.